Form 4: CCC Intelligent Solutions Holdings Inc. Director Sells Shares in Public Offering

Sentiment:

SEC Form 4 Filing


Christopher Egan, a director at CCC Intelligent Solutions Holdings Inc., sold shares of common stock as part of a public offering.

Capital raiseThe shares of Common Stock were sold in connection with an underwritten public offering of the Common Stock of the Issuer (including pursuant to the underwriters exercise of their over-allotment option) pursuant to the prospectus supplement filed March 4, 2024, and accompanying registration statement on Form S-3 (File No. 333-267793).The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions.

Summary

  • Christopher Egan, a director of CCC Intelligent Solutions Holdings Inc., reported the sale of common stock on March 4, 2024.
  • The sales were executed at a price of $11.33 per share.
  • The transactions were part of an underwritten public offering of the company's common stock.
  • Egan also indirectly holds shares through various Advent International entities.
  • After the reported transactions, Egan directly owns 0 shares and indirectly owns 163,275,807 shares through Cypress Investor Holdings, L.P., 5,164,022 shares through Advent International GPE VIII-C Limited Partnership, and 54,148,681 shares through GPE VIII CCC Co-Investment (Delaware) Limited Partnership.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to a stock sale. The sentiment is neutral as it simply reports facts without expressing any positive or negative views.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and large shareholders, providing transparency into their transactions in the company's stock. This sale occurred in connection with a public offering, which is a common method for companies to raise capital.

Stakeholder Impact

  • The public offering could dilute existing shareholders' ownership.
  • The sale by a director might be perceived negatively by some investors, although it's part of a larger offering.

Key Dates

DateDescription
03/04/2024Date of stock sale transaction and prospectus supplement filing.
03/06/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.